Feature|Videos|February 19, 2025
Accelerate Inclusive Enrollment and Delivery with Lightship
Author(s)Lightship
David MacMurchy, Chief Executive Officer at Lightship, offers some insights into the company's mission toward improving equity and diversity in clinical trials.
Lightship focuses on patient accessibility and centricity in clinical trials, ensuring the patient experience is a positive one. Learn more about:
- Lightship's impact on achieving diversity in clinical trials by engaging underrepresented patient populations
- How Lightship utilizes hybrid and decentralized trial designs to reduce patient burden
- The impact a patient centric model has on clinical trial participation and outcomes
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
AbbVie and Genmab Secure FDA Approval for Epkinly Combination in Second-Line Plus Follicular Lymphoma
2
The Future is Now: Four Ways AI and Other Tech Advances are Enhancing Clinical Trials
3
Managing Operational and Compliance Challenges on Emerging Platforms
4
Ziihera Combinations Show Significant Survival Benefits in Phase III HER2+ GEA Trial
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
